Automated antimicrobial susceptibility testing market analysis | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING
  MARKET ANALYSIS
• Automated Antimicrobial Susceptibility Testing
  Market, By Product Type (Consumables and
  Instruments), By Detection Method (Turbidimetric
  and Colorimetric), By Application (Antibacterial
  (Tuberculosis and Sepsis), Antifungal,
  Anti-parasitic, and Anti-viral), By End User
  (Pharmaceutical and Biotechnology Companies,
  Contract Research Organizations, Hospitals, and
  Pathology/Diagnostic Laboratories), and By Region
  (North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa) Size, Share,
  Outlook, and Opportunity Analysis, 2018-2026

3

• Automated antimicrobial susceptibility testing is
  extensively used to achieve minimum inhibitory
  concentration (MIC) results using an
  antimicrobial susceptibility testing system,
  which offers flexible, customizable testing
  options to accommodate laboratories of all sizes.
  Antimicrobial susceptibility testing (AST) aims
  to ensure that suitable antibiotics are
  prescribed to individuals by monitoring
  inhibition zone of antibiotics and emergence of
  resistant pathogens in infected individuals.
  Information on local patterns of antimicrobial
  susceptibility can be collected using
  antimicrobial susceptibility testing, so that
  policies guiding the therapy can be based on
  current data on local resistance trends or
  institutional antibiogram.
• The global automated antimicrobial susceptibility
  testing market size was valued at US 1,295.5
  million in 2018 and is expected to witness a CAGR
  of 8.9 over the forecast period (2018 2026).

4

• Global Automated Antimicrobial Susceptibility
  Testing Market Share () Analysis, By Product
  Type, 2018

5

• Emergence of multidrug resistance worldwide is
  expected to drive growth of the automated
  antimicrobial susceptibility testing market
• Increasing number of multidrug resistance cases
  in tuberculosis (TB), malaria, HIV, influenza,
  and others among the global population is
  expected to result in increasing adoption of
  antimicrobial susceptibility testing to reduce
  the resistance exposure during the forecast
  period. For instance, according to the World
  Health Organization (WHO), in 2014, there were
  around 480,000 new cases of multidrug-resistant
  tuberculosis (MDR-TB), a form of tuberculosis
  that is resistant to the two most powerful
  anti-TB drugs. Among these, only around 123,000
  cases were detected and reported.
• Moreover, increasing number of product launches
  is also expected to highly contribute to the
  automated antimicrobial susceptibility testing
  market growth. For instance, in March 2016,
  Becton, Dickinson and Company launched the new BD
  Phoenix M50 ID/AST system, which helps to deliver
  the same rapid, accurate, and cost-effective
  testing as the legacy BD Phoenix 100, within a
  small footprint.

6
Automated Antimicrobial Susceptibility Testing
Market - Restraints

• Challenges in automated antimicrobial
  susceptibility testing include stringent rules
  and regulations from regulatory bodies, which
  hinders growth of the automated antimicrobial
  susceptibility testing market size. For instance,
  in the European Union, antimicrobial
  susceptibility testing (AST) systems are
  regulated by the Directive 98/79/EC (IVD
  directive), which was changed in 2017 with the
  introduction of the Regulation 2017/746 of the
  European Parliament and of the Council. It
  requires design, development, and manufacturing
  to be performed under a quality system according
  to ISO 13485.

7
Automated Antimicrobial Susceptibility Testing
Market - Regional Insights

• On the basis of region, the global automated
  antimicrobial susceptibility testing market is
  segmented into North America, Latin America,
  Europe, Asia Pacific, Middle East, and Africa.
  North America is expected to hold a dominant
  position in the global automated antimicrobial
  susceptibility testing market during the forecast
  period, owing to development of new antimicrobial
  testing procedures and increasing awareness among
  people regarding antimicrobial resistance (AMR).
  For instance, in April 2018, the U.S. Food and
  Drug Administration approved Thermo Scientific
  Sensititre ID/AST System, the first to offer
  delafloxacin and meropenem/vaborbactam on
  IVD-labeled, microbroth dilution susceptibility
  plates. The antimicrobials are currently
  available in the U.S. on Sensititre custom plates
  and are expected be available soon in new
  standard formats.
• Asia Pacific is expected to witness rapid growth
  in the automated antimicrobial susceptibility
  testing market, owing to high prevalence of
  microbial infections and increasing consumption
  of antibiotics, eventually developing resistance
  among the population. For instance, according to
  a 2014 WHO report, multidrug-resistant
  tuberculosis rates were high in India, especially
  among those who were previously treated and
  treatment for the disease is generally limited.

8
Global Automated Antimicrobial Susceptibility
Testing Market Value (US Mn) Y-o-Y Growth (),
2016-2026

• Automated Antimicrobial Susceptibility Testing
  Market - Competitive Landscape
• Key players operating in the global automated
  antimicrobial susceptibility testing market
  include bioMérieux S.A., HiMedia Laboratories,
  Alifax Holding S.p.A., Creative Diagnostics,
  Resistell AG, Danaher Corporation, Becton,
  Dickinson and Company, Thermo Fisher Scientific
  Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/automated-antimicrobial-susceptibil
  ity-testing-market-2622

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

12
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/